Filtros : "HIPOCAMPO" "ESQUIZOFRENIA" Removido: "NEUROFARMACOLOGIA" Limpar

Filtros



Limitar por data


  • Fonte: Schizophrenia Bulletin. Unidade: FMRP

    Assuntos: POTENCIAIS DE AÇÃO, NEUROTRANSMISSORES, ESQUIZOFRENIA, HIPOCAMPO

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAVICHIOLI, Andreza M. et al. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, v. 49, n. 1, p. 68-77, 2023Tradução . . Disponível em: https://doi.org/10.1093/schbul/sbac106. Acesso em: 08 ago. 2024.
    • APA

      Cavichioli, A. M., Silva, T. S., Grace, A. A., Guimarães, F. S., & Gomes, F. V. (2023). Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, 49( 1), 68-77. doi:10.1093/schbul/sbac106
    • NLM

      Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1093/schbul/sbac106
    • Vancouver

      Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1093/schbul/sbac106
  • Fonte: Human brain mapping. Unidade: FM

    Assuntos: MAPEAMENTO CEREBRAL, ESQUIZOFRENIA, HIPOCAMPO, ANTIPSICÓTICOS

    Acesso à fonteAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GUTMAN, Boris A et al. A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium. Human brain mapping, v. 43, n. 1, p. 352-372, 2022Tradução . . Disponível em: https://doi.org/10.1002/hbm.25625. Acesso em: 08 ago. 2024.
    • APA

      Gutman, B. A., Erp, T. G. M. van, Alpert, K., Ching, C. R. K., Isaev, D., Ragothaman, A., et al. (2022). A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium. Human brain mapping, 43( 1), 352-372. doi:10.1002/hbm.25625
    • NLM

      Gutman BA, Erp TGM van, Alpert K, Ching CRK, Isaev D, Ragothaman A, Jahanshad N, Saremi A, Zavaliangos-Petropulu A, Busatto Filho G. A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium [Internet]. Human brain mapping. 2022 ; 43( 1): 352-372.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1002/hbm.25625
    • Vancouver

      Gutman BA, Erp TGM van, Alpert K, Ching CRK, Isaev D, Ragothaman A, Jahanshad N, Saremi A, Zavaliangos-Petropulu A, Busatto Filho G. A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium [Internet]. Human brain mapping. 2022 ; 43( 1): 352-372.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1002/hbm.25625
  • Fonte: Biological Psychiatry. Unidade: FMRP

    Assuntos: HIPOCAMPO, TRANSTORNOS PSICÓTICOS, NEUROTRANSMISSORES, ESQUIZOFRENIA

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GOMES, Felipe Villela. Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis. Biological Psychiatry, v. 91, n. 2, p. e7-e9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.biopsych.2021.10.019. Acesso em: 08 ago. 2024.
    • APA

      Gomes, F. V. (2022). Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis. Biological Psychiatry, 91( 2), e7-e9. doi:10.1016/j.biopsych.2021.10.019
    • NLM

      Gomes FV. Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis [Internet]. Biological Psychiatry. 2022 ; 91( 2): e7-e9.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1016/j.biopsych.2021.10.019
    • Vancouver

      Gomes FV. Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis [Internet]. Biological Psychiatry. 2022 ; 91( 2): e7-e9.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1016/j.biopsych.2021.10.019
  • Fonte: Neuropsychopharmacology. Unidade: FMRP

    Assuntos: MODELOS ANIMAIS DE DOENÇAS, HIPOCAMPO, ESQUIZOFRENIA

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KIEMES, Amanda et al. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, v. 47, n. 3, p. 687-695, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41386-021-01213-0. Acesso em: 08 ago. 2024.
    • APA

      Kiemes, A., Gomes, F. V., Cash, D., Uliana, D. L., Simmons, C., Singh, N., et al. (2022). GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, 47( 3), 687-695. doi:10.1038/s41386-021-01213-0
    • NLM

      Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1038/s41386-021-01213-0
    • Vancouver

      Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1038/s41386-021-01213-0
  • Fonte: International Journal of Molecular Sciences. Unidade: FMRP

    Assuntos: AGENTES DOPAMINÉRGICOS, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, HIPOCAMPO, ESTRESSE, GLUTAMATOS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GOMES, Felipe Villela e GRACE, Anthony A. Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention. International Journal of Molecular Sciences, v. 22, n. 9, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22094467. Acesso em: 08 ago. 2024.
    • APA

      Gomes, F. V., & Grace, A. A. (2021). Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention. International Journal of Molecular Sciences, 22( 9), 1-18. doi:10.3390/ijms22094467
    • NLM

      Gomes FV, Grace AA. Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 9): 1-18.[citado 2024 ago. 08 ] Available from: https://doi.org/10.3390/ijms22094467
    • Vancouver

      Gomes FV, Grace AA. Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 9): 1-18.[citado 2024 ago. 08 ] Available from: https://doi.org/10.3390/ijms22094467
  • Fonte: Frontiers in Psychiatry. Unidade: FMRP

    Assuntos: NEUROTRANSMISSORES, HIPOCAMPO, CÓRTEX PRÉ-FRONTAL, TÁLAMO, ESQUIZOFRENIA

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SONNENSCHEIN, Susan F. e GOMES, Felipe Villela e GRACE, Anthony A. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia. Frontiers in Psychiatry, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2020.00613. Acesso em: 08 ago. 2024.
    • APA

      Sonnenschein, S. F., Gomes, F. V., & Grace, A. A. (2020). Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia. Frontiers in Psychiatry, 11. doi:10.3389/fpsyt.2020.00613
    • NLM

      Sonnenschein SF, Gomes FV, Grace AA. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia [Internet]. Frontiers in Psychiatry. 2020 ; 11[citado 2024 ago. 08 ] Available from: https://doi.org/10.3389/fpsyt.2020.00613
    • Vancouver

      Sonnenschein SF, Gomes FV, Grace AA. Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia [Internet]. Frontiers in Psychiatry. 2020 ; 11[citado 2024 ago. 08 ] Available from: https://doi.org/10.3389/fpsyt.2020.00613

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024